Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
21 |
Material Type: Article
|
TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic TargetsNeurotherapeutics, 2015-04, Vol.12 (2), p.352-363 [Peer Reviewed Journal]The Author(s) 2015 ;The American Society for Experimental NeuroTherapeutics, Inc. 2015 ;ISSN: 1933-7213 ;ISSN: 1878-7479 ;EISSN: 1878-7479 ;DOI: 10.1007/s13311-015-0338-x ;PMID: 25652699Full text available |
|
22 |
Material Type: Article
|
Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTDNeurotherapeutics, 2022-07, Vol.19 (4), p.1061-1084 [Peer Reviewed Journal]The American Society for Experimental NeuroTherapeutics, Inc. 2022 ;2022. The American Society for Experimental NeuroTherapeutics, Inc. ;The American Society for Experimental NeuroTherapeutics, Inc. 2022. ;ISSN: 1933-7213 ;ISSN: 1878-7479 ;EISSN: 1878-7479 ;DOI: 10.1007/s13311-022-01260-5 ;PMID: 35790708Full text available |
|
23 |
Material Type: Article
|
CDC7 inhibition blocks pathological TDP-43 phosphorylation and neurodegenerationAnnals of neurology, 2013-07, Vol.74 (1), p.39-52 [Peer Reviewed Journal]Copyright © 2013 American Neurological Association ;Copyright © 2013 American Neurological Association. ;ISSN: 0364-5134 ;EISSN: 1531-8249 ;DOI: 10.1002/ana.23870 ;PMID: 23424178Full text available |
|
24 |
Material Type: Article
|
Selective Motor Neuron Resistance and Recovery in a New Inducible Mouse Model of TDP-43 ProteinopathyThe Journal of neuroscience, 2016-07, Vol.36 (29), p.7707-7717 [Peer Reviewed Journal]Copyright © 2016 the authors 0270-6474/16/367707-11$15.00/0. ;Copyright © 2016 the authors 0270-6474/16/367707-11$15.00/0 2016 ;ISSN: 0270-6474 ;EISSN: 1529-2401 ;DOI: 10.1523/JNEUROSCI.1457-16.2016 ;PMID: 27445147Full text available |
|
25 |
Material Type: Article
|
Abstract 1635 The role of Spermidine/spermine N1-acetyltransferase 1 and the polyamine stress response in TDP-43 proteinopathiesThe Journal of biological chemistry, 2024-03, Vol.300 (3) [Peer Reviewed Journal]2024 The American Society for Biochemistry and Molecular Biology, Inc. ;ISSN: 0021-9258 ;EISSN: 1083-351X ;DOI: 10.1016/j.jbc.2024.106942Full text available |
|
26 |
Material Type: Article
|
Abstract 2222 Aggregation of TDP-43 in cellular overexpression model of ALSThe Journal of biological chemistry, 2024-03, Vol.300 (3) [Peer Reviewed Journal]2024 The American Society for Biochemistry and Molecular Biology, Inc. ;ISSN: 0021-9258 ;EISSN: 1083-351X ;DOI: 10.1016/j.jbc.2024.107066Full text available |
|
27 |
Material Type: Article
|
Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43Proceedings of the National Academy of Sciences - PNAS, 2012-09, Vol.109 (37), p.15024-15029 [Peer Reviewed Journal]copyright © 1993-2008 National Academy of Sciences of the United States of America ;Copyright National Academy of Sciences Sep 11, 2012 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1206362109 ;PMID: 22932872Full text available |
|
28 |
Material Type: Article
|
Traumatic injury compromises nucleocytoplasmic transport and leads to TDP-43 pathologyeLife, 2021-06, Vol.10 [Peer Reviewed Journal]2021, Anderson et al. ;2021, Anderson et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021, Anderson et al 2021 Anderson et al ;ISSN: 2050-084X ;EISSN: 2050-084X ;DOI: 10.7554/eLife.67587 ;PMID: 34060470Full text available |
|
29 |
Material Type: Article
|
RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43Neuron (Cambridge, Mass.), 2019-04, Vol.102 (2), p.321-338.e8 [Peer Reviewed Journal]2019 Elsevier Inc. ;Copyright © 2019 Elsevier Inc. All rights reserved. ;2019. Elsevier Inc. ;ISSN: 0896-6273 ;EISSN: 1097-4199 ;DOI: 10.1016/j.neuron.2019.01.048 ;PMID: 30826182Full text available |
|
30 |
Material Type: Article
|
Cytoplasmic TDP-43 De-mixing Independent of Stress Granules Drives Inhibition of Nuclear Import, Loss of Nuclear TDP-43, and Cell DeathNeuron (Cambridge, Mass.), 2019-04, Vol.102 (2), p.339-357.e7 [Peer Reviewed Journal]2019 Elsevier Inc. ;Copyright © 2019 Elsevier Inc. All rights reserved. ;2019. Elsevier Inc. ;ISSN: 0896-6273 ;EISSN: 1097-4199 ;DOI: 10.1016/j.neuron.2019.02.038 ;PMID: 30853299Full text available |
|
31 |
Material Type: Article
|
High glycine content in TDP-43: a potential culprit in limbic-predominant age-related TDP-43 encephalopathyJournal of international medical research, 2020-06, Vol.48 (6), p.300060520929853-300060520929853 [Peer Reviewed Journal]The Author(s) 2020 ;The Author(s) 2020. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 2020 SAGE Publications ;ISSN: 0300-0605 ;EISSN: 1473-2300 ;DOI: 10.1177/0300060520929853 ;PMID: 32529876Full text available |
|
32 |
Material Type: Article
|
Effective Inhibition of TDP‐43 Aggregation by Native State StabilizationAngewandte Chemie International Edition, 2024-01 [Peer Reviewed Journal]Attribution - NonCommercial ;ISSN: 1433-7851 ;EISSN: 1521-3773 ;DOI: 10.1002/anie.202314587 ;PMID: 37949836Digital Resources/Online E-Resources |
|
33 |
Material Type: Article
|
Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 speciesJournal of cell science, 2014-03, Vol.127 (Pt 6), p.1263-1278 [Peer Reviewed Journal]2014. Published by The Company of Biologists Ltd 2014 ;ISSN: 0021-9533 ;EISSN: 1477-9137 ;DOI: 10.1242/jcs.140087 ;PMID: 24424030Full text available |
|
34 |
Material Type: Article
|
Templated Aggregation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Seeding with TDP-43 Peptide FibrilsThe Journal of biological chemistry, 2016-04, Vol.291 (17), p.8896-8907 [Peer Reviewed Journal]2016 © 2016 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology. ;2016 by The American Society for Biochemistry and Molecular Biology, Inc. ;2016 by The American Society for Biochemistry and Molecular Biology, Inc. 2016 The American Society for Biochemistry and Molecular Biology, Inc. ;ISSN: 0021-9258 ;EISSN: 1083-351X ;DOI: 10.1074/jbc.M115.713552 ;PMID: 26887947Full text available |
|
35 |
Material Type: Article
|
Alternatively spliced ELAVL3 cryptic exon 4a causes ELAVL3 downregulation in ALS TDP-43 proteinopathyActa neuropathologica, 2024-05, Vol.147 (1) [Peer Reviewed Journal]The Author(s) 2024 ;ISSN: 0001-6322 ;EISSN: 1432-0533 ;DOI: 10.1007/s00401-024-02732-yDigital Resources/Online E-Resources |
|
36 |
Material Type: Article
|
Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteinsNature communications, 2023-10, Vol.14 (1), p.6492-6492, Article 6492 [Peer Reviewed Journal]2023. Springer Nature Limited. ;The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Springer Nature Limited 2023 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-023-42147-z ;PMID: 37838698Full text available |
|
37 |
Material Type: Article
|
TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementiaBrain (London, England : 1878), 2016-11, Vol.139 (11), p.2983-2993 [Peer Reviewed Journal]The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2016 ;ISSN: 0006-8950 ;EISSN: 1460-2156 ;DOI: 10.1093/brain/aww224 ;PMID: 27694152Full text available |
|
38 |
Material Type: Article
|
Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patientsNature communications, 2014-09, Vol.5 (1), p.4824, Article 4824 [Peer Reviewed Journal]Copyright Nature Publishing Group Sep 2014 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/ncomms5824 ;PMID: 25215604Full text available |
|
39 |
Material Type: Article
|
Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disordersHuman molecular genetics, 2013-10, Vol.22 (R1), p.R77-R87 [Peer Reviewed Journal]The Author 2013. Published by Oxford University Press. 2013 ;ISSN: 0964-6906 ;EISSN: 1460-2083 ;DOI: 10.1093/hmg/ddt349 ;PMID: 23900071Full text available |
|
40 |
Material Type: Article
|
Different 8-Hydroxyquinolines Protect Models of TDP-43 Protein, α-Synuclein, and Polyglutamine Proteotoxicity through Distinct MechanismsThe Journal of biological chemistry, 2012-02, Vol.287 (6), p.4107-4120 [Peer Reviewed Journal]2012 © 2012 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology. ;2012 by The American Society for Biochemistry and Molecular Biology, Inc. 2012 ;ISSN: 0021-9258 ;EISSN: 1083-351X ;DOI: 10.1074/jbc.M111.308668 ;PMID: 22147697Full text available |